Based on its first-half...
Live News EQUITY H impact Jul 16, 2026, 01:29 PM UTC Harmony Biosciences reaffirms FY26 net product revenue guidance $1B-$1.04B Based on its first-half... HRMY.USEQUIT SquawkNews Newsroom Based on its first-half...